Injectable Egg-Free Influenza Vaccine
ID: SPE2DP-24-R-0006Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/2092cc730288461798e14bf87a23b8ce/view
Timeline
    Description

    The Defense Logistics Agency (DLA) Troop Support is seeking suppliers for an Injectable Egg-Free Influenza Vaccine for the upcoming 2025-2026 flu season, with an estimated requirement of approximately 280,000 doses. The vaccine must be FDA-approved for individuals aged 18 and older, and the successful contractor will need to ensure that the vaccine is ACIP recommended, with specific delivery schedules outlined for the ordered quantities. This procurement is critical for maintaining public health and readiness, and interested vendors should prepare for the solicitation SPE2DP-24-R-0006, expected to be issued around October 18, 2024, with further details available on the DLA Bid Board System and SAM.gov. For inquiries, contact Yu Chen at yu.chen@dla.mil or call 215-737-2103.

    Point(s) of Contact
    Yu Chen
    (215) 737-2103
    yu.chen@dla.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Injectable Egg-Free Influenza Vaccine
    Currently viewing
    Presolicitation
    Similar Opportunities
    Injectable Influenza Vaccine
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency Troop Support, is soliciting offers for the procurement of an Injectable Influenza Vaccine under solicitation SPE2DP24R0003 and Amendment 0001. This contract aims to secure a reliable supply of influenza vaccines, which are critical for maintaining the health and readiness of military personnel. Interested vendors should note that the offer due date is set for October 23, 2024, at 3:00 PM local time, and they can reach out to Kevin Weintraub at kevin.weintraub@dla.mil or Yu Chen at yu.chen@dla.mil for further inquiries.
    2025 Southern Hemisphere Influenza Vaccine
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is soliciting proposals for the 2025 Southern Hemisphere Influenza Vaccine. This procurement aims to secure the necessary biological products to support immunization efforts for the upcoming influenza season. The vaccines are critical for public health and military readiness, ensuring that personnel are protected against seasonal influenza strains. Interested vendors can reach out to Rosbert Jones at rosbert.jones@dla.mil or 215-737-2380, or Yu Chen at yu.chen@dla.mil or 215-737-2103 for further details regarding the solicitation process.
    Dimethyl Fumarate DR Presolicitation
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Azithromycin Suspension
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Azithromycin Suspension, specifically in 200MG/5ML bottles of 15ML, 22.5ML, and 30ML sizes. This procurement aims to establish a national supply source for these pharmaceutical products, which are critical for various healthcare needs within the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, and is expected to be fully competitive and unrestricted. Interested parties should prepare for the solicitation, projected for October 2024, and can contact Kahaun Vicks at 215-737-0652 or Kahaun.Vicks@dla.mil for further inquiries.
    Flu Vaccine Storage and Rotation - Notice of Intent to Sole Source
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Seqirus USA Inc. for the storage and rotation of influenza vaccine stockpiles. This procurement aims to ensure the availability of pediatric vaccines manufactured by Seqirus USA Inc. in the national stockpile, which is critical for responding to potential disease outbreaks or vaccine shortages. Interested parties may express their interest and capability to fulfill this requirement, with all responses considered by the government within fifteen days of the notice's issuance. Quotations should be submitted via email to the contract specialist at uuu0@cdc.gov by close of business on October 22, 2024.
    Emergency Thermal Blanket – Hypothermia Prevention
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for the MD-2409-55 Emergency Thermal Blanket designed for hypothermia prevention. This initiative aims to solicit information and products for evaluation, focusing on low-weight, low-bulk blankets that help maintain warmth in emergency cold weather conditions and are intended for single patient use. The blankets will be manufactured in compliance with the Trade Agreements Act (TAA) and must be on the Distribution and Pricing Agreement (DAPA) for the DLA Troop Support Medical/Surgical Prime Vendor program. Interested vendors should ensure their accounts are active in the System for Award Management (SAM) and prepare for the QSL Announcement expected to be released around December 12, 2024. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    Vaginal Specula Disposable
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Disposable Vaginal Specula. This initiative aims to solicit information and products for evaluation, focusing on single-use, sterile and non-sterile Pederson style vaginal specula in various sizes, which will be utilized in outpatient OB/GYN, emergency department, or urgent care settings, excluding surgical procedures. Interested vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and ensure compliance with the Trade Agreements Act (TAA), with the QSL Announcement expected to be released on or about February 2, 2025. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or the MMESO Enterprise Wide Standardization at dha.detrick.med-log.mbx.mmeso@mail.mil.
    FMD Vaccine Sources Sought
    Active
    Agriculture, Department Of
    The U.S. Department of Agriculture, specifically the Animal and Plant Health Inspection Service, is conducting a sources-sought notice to identify manufacturers capable of producing, storing, and delivering Foot and Mouth Disease (FMD) vaccines. The USDA aims to enhance its vaccine preparedness by acquiring sufficient quantities of FMD vaccines or vaccine precursors to support response activities in the event of an outbreak, focusing on both inactivated products and novel vaccine platforms. This initiative is critical for safeguarding the U.S. livestock industry from the severe economic and health impacts of FMD, with responses due by 1:00 PM EST on October 25, 2024. Interested parties should submit their capability statements to Amanda Imlach at amanda.imlach@usda.gov and Charmion Harris at charmion.harris@usda.gov.
    Doxycycline Hyclate
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Doxycycline Hyclate. The contract will establish a national supply source to provide Doxycycline Hyclate 100MG Tablets in various bottle sizes. This acquisition is for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be firm-fixed price, requirements type with a one year base and four one year options. Interested parties should contact Catherine Gilbert for more information. The projected solicitation date is September 2019.
    Syringes With Permanently Attached Safety Needles
    Active
    Dept Of Defense
    Presolicitation notice from the DEPT OF DEFENSE, DEFENSE LOGISTICS AGENCY, DLA TROOP SUPPORT, is anticipated for the establishment of a Qualified Suppliers Listing (QSL) for Syringes With Permanently Attached Safety Needles. The purpose of this notice is to gather information and products for evaluation in order to create a QSL. The syringes with permanently attached safety needles are single-use, sterile, plastic syringes with milliliter (ML) or cubic centimeter (CC) graduation markings and engineered sharps injury prevention feature. These syringes will be available in various volumes, needle lengths, and gauges. The objective is to standardize the product line and create an Incentive Agreement (IA) as part of the MSPV program executed by DLA Troop Support. Vendors interested in participating in the QSL process must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the current Medical/Surgical Prime Vendor (MSPV) for each MMESO Area of Responsibility (AOR). All proposed items must be on DAPA for the DLA Troop Support MSPV program and manufactured in a Trade Agreements Act (TAA) Compliant Country. The release of the QSL Announcement is imminent and all relevant information will be available on the SAM.gov website. This notice is for information purposes only and does not require submission of proposals or qualifications at this time.